Acquired non-inflammatory myopathy: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Acquired non-inflammatory myopathy | |||
| image =[[File:Genga_36.jpg]] | |||
| caption = Illustration of muscle anatomy | |||
| field = [[Neurology]] | |||
| symptoms = Muscle weakness, muscle atrophy | |||
| complications = [[Respiratory failure]], [[cardiac complications]] | |||
| onset = Variable, depending on underlying cause | |||
| duration = Chronic | |||
| causes = [[Endocrine disorders]], [[metabolic disorders]], [[toxic myopathies]], [[drug-induced myopathies]] | |||
| risks = [[Genetic predisposition]], [[environmental factors]] | |||
| diagnosis = [[Clinical evaluation]], [[muscle biopsy]], [[electromyography]], [[blood tests]] | |||
| differential = [[Inflammatory myopathy]], [[muscular dystrophy]], [[neuropathy]] | |||
| treatment = Addressing underlying cause, [[physical therapy]], [[occupational therapy]], [[supportive care]] | |||
| prognosis = Variable, depending on cause and treatment | |||
| frequency = Rare | |||
}} | |||
{{Short description|A group of muscle diseases not caused by inflammation}} | {{Short description|A group of muscle diseases not caused by inflammation}} | ||
Latest revision as of 04:37, 4 April 2025
| Acquired non-inflammatory myopathy | |
|---|---|
| |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Muscle weakness, muscle atrophy |
| Complications | Respiratory failure, cardiac complications |
| Onset | Variable, depending on underlying cause |
| Duration | Chronic |
| Types | N/A |
| Causes | Endocrine disorders, metabolic disorders, toxic myopathies, drug-induced myopathies |
| Risks | Genetic predisposition, environmental factors |
| Diagnosis | Clinical evaluation, muscle biopsy, electromyography, blood tests |
| Differential diagnosis | Inflammatory myopathy, muscular dystrophy, neuropathy |
| Prevention | N/A |
| Treatment | Addressing underlying cause, physical therapy, occupational therapy, supportive care |
| Medication | N/A |
| Prognosis | Variable, depending on cause and treatment |
| Frequency | Rare |
| Deaths | N/A |
A group of muscle diseases not caused by inflammation
Acquired non-inflammatory myopathy refers to a group of muscle diseases characterized by muscle weakness and dysfunction that are not caused by inflammation. These conditions can result from a variety of causes, including metabolic disorders, toxins, and genetic factors. Unlike inflammatory myopathies, these conditions do not involve the immune system attacking muscle tissue.
Classification[edit]
Acquired non-inflammatory myopathies can be classified based on their underlying causes:
Metabolic Myopathies[edit]
Metabolic myopathies are caused by defects in the biochemical pathways that provide energy to muscle cells. These include:
- Glycogen storage diseases: Conditions such as Pompe disease and McArdle disease result from enzyme deficiencies that affect glycogen metabolism.
- Mitochondrial myopathies: These are caused by defects in the mitochondria, the energy-producing structures within cells.
Toxic Myopathies[edit]
Toxic myopathies result from exposure to substances that damage muscle tissue. Common causes include:
- Alcoholic myopathy: Chronic alcohol consumption can lead to muscle weakness and atrophy.
- Drug-induced myopathy: Certain medications, such as statins and colchicine, can cause muscle damage.

Endocrine Myopathies[edit]
Endocrine myopathies are associated with hormonal imbalances. Examples include:
- Hyperthyroid myopathy: Muscle weakness associated with an overactive thyroid gland.
- Hypothyroid myopathy: Muscle weakness due to an underactive thyroid gland.
Critical Illness Myopathy[edit]
This condition occurs in patients who are critically ill, often in intensive care units. It is characterized by muscle weakness and is associated with prolonged immobilization and the use of certain medications.
Symptoms[edit]
The primary symptom of acquired non-inflammatory myopathy is muscle weakness, which can vary in severity. Other symptoms may include:
- Muscle cramps
- Fatigue
- Difficulty with physical activities
Diagnosis[edit]
Diagnosis of acquired non-inflammatory myopathy involves a combination of clinical evaluation, laboratory tests, and imaging studies. Common diagnostic tools include:
- Electromyography (EMG): This test measures the electrical activity of muscles and can help differentiate between myopathic and neuropathic conditions.

- Muscle biopsy: A small sample of muscle tissue is examined under a microscope to identify structural abnormalities.
- Blood tests: These can detect elevated levels of muscle enzymes, such as creatine kinase, which indicate muscle damage.
Treatment[edit]
Treatment of acquired non-inflammatory myopathy depends on the underlying cause. General approaches include:
- Addressing the underlying cause: For example, discontinuing a medication that is causing muscle damage or treating a hormonal imbalance.
- Physical therapy: Helps maintain muscle strength and function.

- Nutritional support: Ensuring adequate nutrition to support muscle health.
Prognosis[edit]
The prognosis for individuals with acquired non-inflammatory myopathy varies depending on the specific condition and its severity. Some conditions may improve with treatment, while others may lead to progressive muscle weakness.
